Decreased benzodiazepine receptor binding in Machado-Joseph disease

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1518-1520

  Ishibashi, Masatoshi ^a   Sakai, Tetsuo ^b   Matsuishi, Toyojiro ^b   Yonekura, Yoshiharu ^b   Yamashita, Yushiro ^b   Abe, Toshi ^b   Ohnishi, Yoshihiro ^b   Hayabuchi, Naofumi ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Benzodiazepine receptor; Iodine 123 iomazenil; Machado Joseph disease; SPECT

Indexed keywords

BENZODIAZEPINE RECEPTOR; IODINE 123; IOMAZENIL;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CASE REPORT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MACHADO JOSEPH DISEASE; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN; CASE-CONTROL STUDIES; FLUMAZENIL; HUMANS; IODINE RADIOISOTOPES; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031710451     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rosenberg RN, Nyhan WL, Bay C, Shore P. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 1976;26:703-714.
2. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene from Machado-Joseph disease at chromosome 14q 32.1. Nature Genet 1994;8:221-227.
3. Hunkeler W, Mohler H, Pieri L, et al. Selective antagonists of benzodiazepines. Nature 1981;290:514-516.
4. Sybirska E, Al-Tikriti MS, Zoghbi SS, Baldwin RM, Johnson EW, Innis RB. SPECT imaging of the benzodiazepine receptor: autoradiographic comparison of receptor density and radioligand distribution. Synapse 1992;12:119-128.
5. Beer HF, Blauenstein PH, Hasler PH, et al. In vitro and in vivo evaluation of iodine-123-Ro16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990;31:1007-1014.
6. Sakai T, Oda K. Abundant reinnervation in peripheral nerves in Joseph disease. Neurology 1993;43:428-430.
7. Ohnishi Y, Yonekura Y, Mukai T, et al. Simple quantification of benzodiazepine receptor binding and ligand receptor transport using iodine 123-iomazenil and two SPECT scans. J Nucl Med 1995;36:1201-1210.
8. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of binding sites with positron emission tomography. Ann Neurol 1984;15:217-227.
9. Ohnishi Y, Yonekura Y, Nishizawa S, et al. Noninvasive quantification of iodine-123-iomazenil SPECT. J Nucl Med 1996;37:374-378.
10. Rosenberg RN. Joseph disease: an autosomal dominant motor system degeneration. In: de Jong JMBV, ed. Handbook of clinical neurology, vol. 16(60). Hereditary neuropathies and spinocerebellar atrophies. Amsterdam: Elsevier; 1991:467-479.
11. Taniwaki T, Sakai T, Kobayashi T, et al. Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 1997;145:63-67.